Canadian Sec - Delayed Quote CAD
Beyond Medical Technologies Inc. (DOCT.CN)
0.2500
-0.0200
(-7.41%)
At close: May 2 at 12:31:55 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
208.6590
Cost of Revenue
--
--
--
1,193.9160
281.9020
Gross Profit
--
--
--
-250.4910
-73.2430
Operating Expense
503.4290
548.4740
836.9240
1,466.8810
1,976.9510
Operating Income
-503.4290
-548.4740
-836.9240
-1,466.8810
-2,050.1940
Net Non Operating Interest Income Expense
--
--
--
-14.2430
-17.9400
Other Income Expense
71.0890
-3.5300
1.8100
-400.7050
-4,452.7990
Pretax Income
-432.3400
-552.0040
-835.1140
-1,867.5860
-6,520.9330
Net Income Common Stockholders
-457.1050
-595.9640
-1,400.8460
-2,912.7580
-6,520.9330
Diluted NI Available to Com Stockholders
-457.1050
-595.9640
-1,400.8460
-2,912.7580
-6,520.9330
Basic EPS
-0.07
-0.08
-0.18
-0.39
-1.40
Diluted EPS
-0.07
-0.08
-0.18
-0.39
-1.40
Basic Average Shares
7,913.9750
7,913.9750
7,913.9750
7,538.7540
4,746.6260
Diluted Average Shares
7,913.9750
7,913.9750
7,913.9750
7,538.7540
4,746.6260
Total Operating Income as Reported
--
--
-838.9410
-1,466.3040
-2,099.8660
Total Expenses
503.4290
548.4740
836.9240
1,466.8810
2,258.8530
Interest Income
--
--
--
--
7.0470
Interest Expense
--
--
--
14.2430
24.9870
Net Interest Income
--
--
--
-14.2430
-17.9400
Net Income from Continuing & Discontinued Operation
-457.1050
-595.9640
-1,400.8460
-2,912.7580
-6,520.9330
Normalized Income
-503.4290
-548.4740
-836.9240
-1,866.8810
-2,068.1340
EBIT
-503.4290
-548.4740
-836.9240
-1,466.8810
-6,495.9460
EBITDA
-503.4290
-548.4740
-836.9240
-1,466.8810
-6,353.5860
Reconciled Cost of Revenue
--
--
--
1,193.9160
281.9020
Reconciled Depreciation
--
--
--
173.0820
142.3600
Net Income from Continuing Operation Net Minority Interest
-432.3400
-552.0040
-835.1140
-1,867.5860
-6,520.9330
Total Unusual Items Excluding Goodwill
71.0890
-3.5300
1.8100
-0.7050
-4,452.7990
Total Unusual Items
71.0890
-3.5300
1.8100
-0.7050
-4,452.7990
Normalized EBITDA
-574.5180
-544.9440
-838.7340
-1,466.1760
-1,900.7870
12/31/2020 - 3/2/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade